Clinical Trial Update: Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"

View source ↗

Summary

This completed clinical trial assessed the long-term use of Leuplin SR 11.25 mg in prostate cancer patients, with 96-week follow-up results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuplin SR 11.25 mg Injection Kit (leuprolide acetate)

Snippet

Sponsor: Takeda | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2017-03-29